10:00 a.m.

Opening Remarks and Day 1 Recap

Workshop and Panel Chair

Director’s Remarks

10:10 a.m.

National Cancer Institute

Anthony Letai, M.D., Ph.D.
Director, National Cancer Institute
National Institutes of Health

10:15 a.m.

Eunice Kennedy Shriver National Institute of Child Health and Human Development

TBD
Senior Leadership
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institutes of Health

Key Question 1b:

Do the effectiveness, comparative effectiveness, and harms of treatment vary by timing and type of menopause (early, average, iatrogenic, natural)?

10:20 a.m.

Surgical-Related Early Transition Timing—Barbara Norquist, M.D.

10:40 a.m.

Iatrogenic Menopause as a Result of Cancer Treatment—Ann Partridge, M.D., M.P.H.

11.00 a.m.

Genitourinary Symptom Management—Jan Shifren, M.D.

11:20 a.m.

Photobiomodulation Therapy of Vaginal Tissue—Raymond Lanzafame, M.D., M.B.A., FACS

11:40 a.m.

Discussion

Moderated by
Workshop & Panel Chair

12:00 p.m.

Break

Key Question 1c:

Do the effectiveness, comparative effectiveness, and harms of treatment vary by individual- or system-level factors?

12:10 p.m.

Evaluating Cancer Risks, Prevention Interventions, and Their Impact on Quality of Life—Carol Fabian, M.D.

12:30 p.m.

Dementia-Related Cognitive Decline—Walter Rocca, M.D., M.P.H.

12:50 p.m.

Musculoskeletal Health During the Menopause Transition—Fabrisia Ambrosio, Ph.D.

1:10 p.m.

Prevention of Cardiovascular Disease Risks to Ensure Overall Heart Health —Samar El Khoudary, Ph.D., M.P.H., FAHA

 1:30 p.m.

Discussion

Moderated by
Workshop & Panel Chair

1:50 p.m.

Lunch Break

General Session 2

Healthy Aging in Women—Supporting Overall Well-Being During the Menopause Transition—Part 2

2:20 p.m.

Moderator Perspectives—Karen Giblin

2:30 p.m.

Perimenopausal-Related Sleep Disturbances—Hadine Joffe, M.D., M.Sc.

2:45 p.m.

Perimenopausal Effects on Memory and Brain Health—Rebecca Thurston, Ph.D.

3:00 p.m.

Mental Health Perspectives on the Increased Use of m-Health Technologies—Claudio Soares, M.D., Ph.D.

3:15 p.m.

Wearable Sensors—Fiona Baker. Ph.D.

3:30 p.m.

Discussion

Moderated by
Karen Giblin

3:50 p.m.

Break

Key Question 2:

What is the impact of individual- or system-level factors on the receipt of treatment for perimenopausal and early postmenopausal women with symptoms?

• Individual-level factors include, but are not limited to, educational attainment, patient engagement in health care, lifestyle factors, and comorbidities.
• System-level factors include, but are not limited to, provider bias, access to care, and social determinants of health.

4:00 p.m.

Evidence-based Practice Center Presentation II

4:30 p.m.

Adjourn